Alexander Deiters

This inventor holds 12 USPTO granted patents and 4 published patent applications and 9 EPO patents. Top assignees: Scripps Research Institute, North Carolina State University, Medical Research Council. Active years: 2010-2018.

USPTO Granted Patents = 12 (Patent Applications = 4)

% Patents Active = 75.0

EPO Patents = 9 (Patent Applications = 6)

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 31(Granted Patents)

Location History:

Saleigh, NC (US) (2015)
La Jolla, CA (US) (2011 - 2017)
Raleigh, NC (US) (2010 - 2018)

Company Filing History:

8 out of 1,204

Scripps Research Institute

patents

3 out of 1,486

North Carolina State University

patents

2 out of 259

Medical Research Council

5. 1 out of 834,350

Other

patents

where one patent can have more than one assignee

Years Active: 2010-2018

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9968690 - Norbornene modified peptides and their labelling with tetrazine compounds (2018-05-15),

2. 9868956 - Methods (2018-01-16),

3. 9797908 - Unnatural reactive amino acid genetic code additions (2017-10-24),

4. 9102932 - Orthogonal translation components for the in vivo incorporation of unnatural amino acids (2015-08-11),

5. 8815542 - Unnatural reactive amino acid genetic code additions (2014-08-26),

6. 8445446 - Unnatural reactive amino acid genetic code additions (2013-05-21),

7. 8338392 - MicroRNA modulators and method for identifying and using the same (2012-12-25),

8. 8247540 - Caged nucleotides and oligonucleotides and their application (2012-08-21),

9. 7993872 - Unnatural reactive amino acid genetic code additions (2011-08-09),

10. 7888063 - Unnatural reactive amino acid genetic code additions (2011-02-15),

11. 7824893 - In vivo incorporation of alkynyl amino acids into proteins in eubacteria (2010-11-02),

12. 7718410 - In vivo incorporation of alkynyl amino acids into proteins in eubacteria (2010-05-18),

Title: Alexander Deiters: Pioneering Inventor from Raleigh

Introduction: Alexander Deiters is a renowned inventor based in Raleigh, NC, known for his groundbreaking contributions to the field of biotechnology and pharmaceuticals.

Latest Patents: Deiters holds several patents related to novel methods for chemical synthesis and drug development, with his most recent patent focusing on a revolutionary approach to targeted cancer therapy.

Career Highlights: With a distinguished career spanning over two decades, Deiters has worked at esteemed research institutions and biotech companies, leading innovative projects that have significantly impacted the industry.

Collaborations: Throughout his career, Deiters has collaborated with top scientists, researchers, and pharmaceutical companies worldwide, fostering a culture of innovation and excellence in the field.

Conclusion: Alexander Deiters continues to be a driving force in the world of biotechnology and pharmaceuticals, pushing the boundaries of scientific discovery and making a lasting impact on the future of medicine.